• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameHAVAB-M EIA
Classification Namehepatitis a test (antibody and igm antibody)
Generic Nameantibody to hepatitus a virus of igm class
Regulation Number866.3310
ApplicantABBOTT LABORATORIES
PMA NumberP790019
Supplement NumberS016
Date Received10/07/2002
Decision Date11/06/2002
Product Code
LOL[ Registered Establishments with LOL ]
Advisory Committee Microbiology
Supplement Type30-day notice
Supplement Reason process change: manufacturing
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Changes to 1) replace lyophilized goat anti-human igm purchased from litton bionetics with non-lyophilized goat anti-human igm purchased from jackson immuno research. 2) replace rheophoresis testing for goat anti-human igm (antibody) identity/specificity with immunoelectro-phoresis (iep) testing. 3) replace havab-m ria (radioimmunoassay) antibody bead coat efficacy testing with small-scale antibody dilution factor determination and confirmation testing using havab-m eia (enzyme immunoassay) to establish the optimal dilution factor of the goat anti-human igm antibody to be used for full-scale production bead coating.
-
-